SCYNEXIS INC Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K covers events occurring on June 25, 2026, and June 26, 2026. SCYNEXIS, Inc. (SCYX) held its 2026 Annual Meeting of Stockholders on June 25, 2026, and subsequently filed a Certificate of Amendment to its Certificate of Incorporation on June 26, 2026. The filing also references a 1-for-8 reverse stock split that took effect on May 29, 2026.
Key Financial Metrics
The filing does not provide specific financial performance metrics such as revenue, profit, cash flow, margins, debt, or liquidity. The document focuses on corporate governance actions, capital structure changes, and shareholder voting results.
Material Changes
- Authorized Share Increase: The Company increased its total authorized shares from 23,750,000 to 65,000,000. Specifically, authorized Common Stock increased from 18,750,000 to 60,000,000 shares.
- Equity Plan Amendment: The 2024 Equity Incentive Plan was amended to increase the aggregate number of shares authorized for issuance by 9,600,000 shares (pre-reverse split basis).
- Warrant Exercisability: Common Warrants held by Selling Stockholders, covering 43,500,000 shares (pre-split) with an exercise price of $1.20 per share, became exercisable upon the effectiveness of the authorized share increase.
Guidance, Outlook, and Shareholder Votes
Management commentary and forward-looking guidance are not included in this filing. The document details the results of six proposals voted on at the Annual Meeting:
- Proposal 1 (Directors): All six nominees were elected. Votes were cast on a pre-reverse split basis.
- Proposal 2 (Auditor): Ratification of Deloitte & Touche LLP was approved (56,745,060 For vs. 1,878,978 Against).
- Proposal 3 (Say-on-Pay): Advisory approval of executive compensation was approved (41,970,140 For vs. 2,076,765 Against).
- Proposal 4 (Say-on-Frequency): Shareholders approved annual (1-year) frequency for future advisory voting (42,700,367 votes).
- Proposal 5 (Equity Plan): The amendment to increase the 2024 Plan share pool was approved (36,621,939 For vs. 7,362,841 Against).
- Proposal 6 (Charter Amendment): The increase in authorized shares was approved (45,814,090 For vs. 12,437,086 Against).
Risks and Contingencies: The filing notes the existence of a Registration Statement on Form S-3 (No. 333-295493) declared effective on May 8, 2026, allowing Selling Stockholders to resell up to 87,000,000 shares (pre-split), including shares from pre-funded warrants and common warrants.
Investor Verification Checklist
- Verify the post-reverse split share counts for the newly authorized 60,000,000 common shares and the 9,600,000 equity plan increase.
- Confirm the current exercise status and potential dilution impact of the 43,500,000 common warrants (pre-split) now exercisable at $1.20 per share.
- Review the definitive proxy statement filed on April 30, 2026, for detailed terms of the Charter Amendment and Equity Plan changes.
- Monitor the resale activity of the 87,000,000 shares registered under Form S-3 by Selling Stockholders.